]>
IRCT20150711023153N3 IRCT 2021-06-04 Yasouj University of Medical Sciences Evaluation the Effects of green tea supplement in Covid 19 patients Evaluation the Effects of Green Tea Supplement on CBC & Inflammatory Biomarkers in Covid 19 Patients: Randomized Clinical Trial; Double blind 2021-07-11 anticipated 74 Complete https://irct.ir/trial/55948 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Patients will be stratify by Block Random sampling based on age and sex in one of 8 blocks of 9 and 10 people and by computer generated random numbers (Randomization.com) in one of two intervention or placebo groups, this list is in the hands of the group's secretary and Who Does not play a role in the study, Blinding description: Blinding of patients, health care professionals, principal investigators as well as data collectors and data analysts will be unaware of the intervention and placebo groups still the end of the study. The intervention includes a placebo or green tea extract capsule in special package and exactly same in color and taste are labeled with different numbers, and the contents of these numbers will be kept in a closed envelope in the faculty and its contents will be preserved until the end of the study. N/A covid19. Intervention 1: Intervention group: Patients receiving 2green tea extract capsule that each one have 450 mlgr twice a day after lunch and after dinner + usual hospital medicine. Intervention 2: Control group: Patients receiving 2 placebo capsule twice a day after lunch and after dinner + usual hospital medicine. Yes - There is a plan to make this available What will be shared: All potential data can be shared after blinding When: Six months after publishing To whom: Researchers working in academic institutions Conditions: For research purposes and meta-analysis studies Where to obtain: Dr. Seyed bahman panahande . Faculty member of the Health and Nutrition, Yasuj University of Medical Sciences How to obtain: Official letter to the researchers Comments:
public Mojtaba Yousefi
Imam khomeini Blvd., Imam Hossein Square, Golestan 15, School of Health and Nutrition, Yasuj
Yasuj Iran (Islamic Republic of) 7591875114 +98 74 3322 5519 mojtaba.yousefi@yums.ac.ir Yasouj University of Medical Sciences scientific Seyed Bahman Panahande
Imam Khomeini Blvd., Imam Hossein Square, Golestan 15, School of Health and Nutrition
Yasuj Iran (Islamic Republic of) 7591875114 +98 74 3322 5519 panahande.b@yums.ac.ir Yasouj University of Medical Sciences Iran (Islamic Republic of) 18 years old or above Written informed consent form COVID-19 diagnosis based on polymerase chain reaction (PCR) Willingness to participate in research study 18 years no limit Both Pregnancy or lactation Disseminated intravascular coagulation or any other types of coagulopathy Severe congestive heart failure by the specialist Other contraindications prescribed by the specialist Participation in any clinical trial within the past 30 days prior to enrollment in the present study U07.1 COVID DISEASE Treatment - Other Placebo Intervention group: Patients receiving 2green tea extract capsule that each one have 450 mlgr twice a day after lunch and after dinner + usual hospital medicine Control group: Patients receiving 2 placebo capsule twice a day after lunch and after dinner + usual hospital medicine CRP. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit. Erythrocyte Sedimentation Rate (ESR). Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Elisa Kit. CBC. Timepoint: Before the intervention and at the end of day 14 study. Method of measurement: Cell counter devices. Yasouj University of Medical Sciences Approved 2021-05-15 Ethics Committee of Yasuj University of Medical Sciences Motahari Blvd., Yasuj University of Medical Sciences, Kohgiluyeh and Boyer Ahmad province, Iran Yasuj Kohgilouyeh-va-Boyrahmad Iran (Islamic Republic of)